Literature DB >> 3011853

Rapid detection of cytomegalovirus in bronchoalveolar lavage specimens by a monoclonal antibody method.

W J Martin, T F Smith.   

Abstract

Cytomegalovirus (CMV), a common cause of pneumonia in immunocompromised subjects, is conventionally diagnosed in the laboratory by tube cell culture assays or by detection of characteristic inclusions in histologic sections. Of 160 immunocompromised patients, CMV infection was diagnosed in 19 subjects by bronchoalveolar lavage (BAL), using a monoclonal antibody directed against an early nuclear antigen of the virus. Cytospin preparations from BAL and MRC-5 cell cultures inoculated with the BAL specimens yielded positive results for 6 (31.6%) and 18 (94%) of the 19 subjects, respectively, within hours of the bronchoscopic procedure, whereas conventional tube cell cultures were positive for 11 of the 19 subjects (57.9%) only after an average of 9.3 days. The monoclonal antibody method permitted easy and rapid detection of CMV in BAL specimens.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011853      PMCID: PMC268781          DOI: 10.1128/jcm.23.6.1006-1008.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens.

Authors:  C A Gleaves; T F Smith; E A Shuster; G R Pearson
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

2.  Detection and serotyping of herpes simplex virus in MRC-5 cells by use of centrifugation and monoclonal antibodies 16 h postinoculation.

Authors:  C A Gleaves; D J Wilson; A D Wold; T F Smith
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

3.  Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen.

Authors:  C A Gleaves; T F Smith; E A Shuster; G R Pearson
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

4.  Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation.

Authors:  J D Meyers; J Leszczynski; J A Zaia; N Flournoy; B Newton; D R Snydman; G G Wright; M J Levin; E D Thomas
Journal:  Ann Intern Med       Date:  1983-04       Impact factor: 25.391

5.  Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host.

Authors:  D E Stover; M B Zaman; S I Hajdu; M Lange; J Gold; D Armstrong
Journal:  Ann Intern Med       Date:  1984-07       Impact factor: 25.391

6.  The diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome using subsegmental bronchoalveolar lavage.

Authors:  F P Ognibene; J Shelhamer; V Gill; A M Macher; D Loew; M M Parker; E Gelmann; A S Fauci; J E Parrillo; H Masur
Journal:  Am Rev Respir Dis       Date:  1984-06

7.  Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.

Authors:  P K Peterson; H H Balfour; S C Marker; D S Fryd; R J Howard; R L Simmons
Journal:  Medicine (Baltimore)       Date:  1980-07       Impact factor: 1.889

8.  Interstitial lung disease. Assessment by bronchoalveolar lavage.

Authors:  W J Martin; D E Williams; D E Dines; D R Sanderson
Journal:  Mayo Clin Proc       Date:  1983-11       Impact factor: 7.616

  8 in total
  23 in total

1.  Quantification of cytomegalovirus in bronchoalveolar lavage fluid after allogeneic marrow transplantation by centrifugation culture.

Authors:  M A Slavin; C A Gleaves; H G Schoch; R A Bowden
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

2.  Rapid demonstration of cytomegalovirus in clinical specimens.

Authors:  P H Rothbarth; R J Diepersloot; H J Metselaar; Y Nooyen; J Velzing; W Weimar
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

3.  Detection of cytomegalovirus antigens and DNA in tissues fixed in formaldehyde.

Authors:  N M Jiwa; A K Raap; F M van de Rijke; A Mulder; J J Weening; F E Zwaan; T H The; M van der Ploeg
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

4.  Direct detection of cytomegalovirus from bronchoalveolar lavage samples by using a rapid in situ DNA hybridization assay.

Authors:  C A Gleaves; D Myerson; R A Bowden; R C Hackman; J D Meyers
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

5.  Comparative recovery of cytomegalovirus from saliva, mucolysed induced sputum, and bronchoalveolar lavage fluid from patients at risk for or with acquired immunodeficiency syndrome.

Authors:  J D Rush; V L Ng; P C Hopewell; W K Hadley; J Mills
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

6.  Comparison of monoclonal antibodies for rapid detection of cytomegalovirus in spin-amplified plate cultures.

Authors:  R Ashley; E Peterson; H Abbo; D Gold; L Corey
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

7.  Detection of cytomegalovirus infections in specimens other than urine by the shell vial assay and conventional tube cell cultures.

Authors:  C V Paya; A D Wold; T F Smith
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

8.  Evaluation of a direct fluorescein-conjugated monoclonal antibody for detection of cytomegalovirus in centrifugation culture.

Authors:  C A Gleaves; C F Lee; L Kirsch; J D Meyers
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

9.  Correlation of cytomegalovirus (CMV) detection in urine by tissue culture virus isolation, early antigen immunofluorescence test and nucleic acid hybridization.

Authors:  G Meyer; G Enders
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

10.  Optimal use of the cytocentrifuge for recovery and diagnosis of Pneumocystis carinii in bronchoalveolar lavage and sputum specimens.

Authors:  V J Gill; N A Nelson; F Stock; G Evans
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.